{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T22:59:47Z","timestamp":1789340387587,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-1172-9-45","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T09:02:19Z","timestamp":1396256539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes"],"prefix":"10.1186","volume":"9","author":[{"given":"Marissa","family":"Orenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Barbouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf A","family":"Bodamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"732_CR1","volume-title":"The Online Metabolic and Molecular Basis of Inherited Metabolic Disease","author":"G Grabowski","year":"2010","unstructured":"Grabowski G, Kolodny E, Weinreb N, Rosenbloom B, Prakash-Cheng A, Kaplan P, Charrow J, Pastores G, Mistry P: Gaucher Disease: Phenotypic and Genetic Variation. The Online Metabolic and Molecular Basis of Inherited Metabolic Disease. Edited by: Scriver C, Beaudet A, Valle D, Slye W. New York: McGraw-Hill Publishers; 2010.http:\/\/ommid.mhmedical.com\/content.aspx?bookid=474&sectionid=45374149,"},{"issue":"4","key":"732_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1399-0004.2006.00688.x","volume":"70","author":"E Sidransky","year":"2006","unstructured":"Sidransky E: Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin Genet. 2006, 70 (4): 275-282. 10.1111\/j.1399-0004.2006.00688.x.","journal-title":"Clin Genet"},{"issue":"20","key":"732_CR3","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1182\/blood-2011-10-386862","volume":"119","author":"SM Lo","year":"2012","unstructured":"Lo SM, Choi M, Liu J, Jain D, Boot RG, Kallemeijn WW, Aerts JM, Pashankar F, Kupfer GM, Mane S, Lifton RP, Mistry PK: Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease\/hematologic malignancy phenotype by individual genome analysis. Blood. 2012, 119 (20): 4731-4740. 10.1182\/blood-2011-10-386862.","journal-title":"Blood"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","volume":"31","author":"M Biegstraaten","year":"2008","unstructured":"Biegstraaten M, van Schaik IN, Aerts JM, Hollak CE: Non-neuronopathic. Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis. 2008, 31: 337-349. 10.1007\/s10545-008-0832-y.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"732_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA. 1999, 281 (3): 249-254. 10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"key":"732_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","volume":"10","author":"TM Cox","year":"1997","unstructured":"Cox TM, Schofield JP: Gaucher\u2019s disease: clinical features and natural history. Ballieres Clin Haematol. 1997, 10: 657-689. 10.1016\/S0950-3536(97)80033-9.","journal-title":"Ballieres Clin Haematol"},{"issue":"19","key":"732_CR7","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R: Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2004, 351 (19): 1972-1977. 10.1056\/NEJMoa033277.","journal-title":"N Engl J Med"},{"issue":"4","key":"732_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J","volume":"12","author":"M Horowitz","year":"1998","unstructured":"Horowitz M, Pasmanik-Chor M, Borochowitz Z, Falik-Zaccai T, Heldmann K, Carmi R, Parvari R, Beit-Or H, Goldman B, Peleg L, Levy-Lahad E, Renbaum P, Legum S, Shomrat R, Yeger H, Benbenisti D, Navon R, Dror V, Shohat M, Magal N, Navot N, Eyal N: Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum Mutat. 1998, 12 (4): 240-244. 10.1002\/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J. Erratum in: Hum Mutat 1999;13(3):255","journal-title":"Hum Mutat"},{"key":"732_CR9","first-page":"4","volume":"6","author":"I Sheskin","year":"2012","unstructured":"Sheskin I, Dashevsky A: Jewish population in the United States. Am Jew. 2012, 6: 4-46. last accessed at http:\/\/www.jewishdatabank.org\/Studies\/details.cfm?StudyID=611","journal-title":"Am Jew"},{"issue":"16","key":"732_CR10","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1001\/archinternmed.2010.302","volume":"170","author":"M Balwani","year":"2010","unstructured":"Balwani M, Fuerstman L, Kornreich R, Edelmann L, Desnick RJ: Type 1 Gaucher disease: significant disease manifestations in \u201casymptomatic\u201d homozygotes. Arch Intern Med. 2010, 170 (16): 1463-1469. doi:10.1001\/archinternmed.2010.302. Erratum in: Arch Intern Med. 2010 Nov 8;170(20):1833","journal-title":"Arch Intern Med"},{"issue":"4","key":"732_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ajh.21362","volume":"84","author":"TH Taddei","year":"2009","unstructured":"Taddei TH, Kacena KA, Yang M, Yang R, Malhotra A, Boxer M, Aleck KA, Rennert G, Pastores GM, Mistry PK: The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients. Am J Hematol. 2009, 84 (4): 208-214. 10.1002\/ajh.21362. 10.1002\/ajh.21362","journal-title":"Am J Hematol"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.20908","volume":"82","author":"PK Mistry","year":"2007","unstructured":"Mistry PK, Sadan S, Yang R, Yee J, Yang M: Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007, 82: 697-701. 10.1002\/ajh.20908.","journal-title":"Am J Hematol"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1172-7-17","volume":"7","author":"P Giraldo","year":"2012","unstructured":"Giraldo P, Alfonso P, Ir\u00fan P, Gort L, Chab\u00e1s A, Vilageliu L, Grinberg D, S\u00e1 Miranda CM, Pocovi M: Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula. Orphanet J Rare Dis. 2012, 7: 17-10.1186\/1750-1172-7-17. 10.1186\/1750-1172-7-17","journal-title":"Orphanet J Rare Dis"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1750-1172-7-77","volume":"7","author":"J Stirnemann","year":"2012","unstructured":"Stirnemann J, Vigan M, Hamroun D, Heraoui D, Rossi-Semerano L, Berger MG, Rose C, Camou F, de Roux-Serratrice C, Grosbois B, Kaminsky P, Robert A, Caillaud C, Froissart R, Levade T, Masseau A, Mignot C, Sedel F, Dobbelaere D, Vanier MT, Valayanopoulos V, Fain O, Fantin B, de Villemeur TB, Mentr\u00e9 F, Belmatoug N: The French Gaucher\u2019s disease registry: clinical characteristics, complications and treatment of 562 patients. Orphanet J Rare Dis. 2012, 7: 77-10.1186\/1750-1172-7-77. 10.1186\/1750-1172-7-77","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"732_CR15","first-page":"273","volume":"72","author":"G Drelichman","year":"2012","unstructured":"Drelichman G, Linares A, Villalobos J, Cabello JF, Kerstenetzky M, Kohan RM, Martins AM: Gaucher disease in Latin America. A report from the Gaucher Disease International Registry and the Latin American Group for Gaucher Disease. Medicina (B Aires). 2012, 72 (4): 273-282.","journal-title":"Medicina (B Aires)"},{"issue":"18","key":"732_CR16","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A: The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000, 160 (18): 2835-2843. 10.1001\/archinte.160.18.2835.","journal-title":"Arch Intern Med"},{"key":"732_CR17","first-page":"1","volume":"12","author":"NJ Weinreb","year":"2009","unstructured":"Weinreb NJ, Cappellini MD, Cox TM, Giannini EH, Grabowski GA, Hwu WL, Mankin H, Martins AM, Sawyer C, Vom Dahl S, Yeh MS, Zimran A: A validated disease severity scoring system for Gaucher disease type 1. Genet Med. 2009, 12: 1-8.","journal-title":"Genet Med"},{"key":"732_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/ajh.21280","volume":"83","author":"NJ Weinreb","year":"2008","unstructured":"Weinreb NJ, Taylor J, Cox T, Yee J, Vom DS: A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase. Am J Hematol. 2008, 83: 890-895. 10.1002\/ajh.21280.","journal-title":"Am J Hematol"},{"key":"732_CR19","volume-title":"Demographic and Economic Characteristics of Southeast Florida","author":"RF Ogburn","year":"2012","unstructured":"Ogburn RF: Demographic and Economic Characteristics of Southeast Florida. 2012, South Florida Regional Planning Council, http:\/\/www.sfrpc.com\/Dick%27s%20Demographics\/SEFloridaMay12_Full.pdf; last accessed September 16, 2013"},{"issue":"12","key":"732_CR20","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","volume":"105","author":"BE Rosenbloom","year":"2005","unstructured":"Rosenbloom BE, Weinreb NJ, Zimran A, Kacena KA, Charrow J, Ward E: Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood. 2005, 105 (12): 4569-4572. 10.1182\/blood-2004-12-4672.","journal-title":"Blood"},{"issue":"1","key":"732_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","volume":"36","author":"M de Fost","year":"2006","unstructured":"de Fost M, Vom Dahl S, Weverling GJ, Brill N, Brett S, H\u00e4ussinger D, Hollak CE: Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis. 2006, 36 (1): 53-58. 10.1016\/j.bcmd.2005.08.004.","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"732_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/10428190600565453","volume":"47","author":"R Costello","year":"2006","unstructured":"Costello R, O\u2019Callaghan T, S\u00e9bahoun G: Gaucher disease and multiple myeloma. Leuk Lymphoma. 2006, 47 (7): 1365-1368. 10.1080\/10428190600565453.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"732_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1615\/CritRevOncog.2013006061","volume":"18","author":"R Ayto","year":"2013","unstructured":"Ayto R, Hughes DA: Gaucher disease and myeloma. Crit Rev Oncog. 2013, 18 (3): 247-268. 10.1615\/CritRevOncog.2013006061.","journal-title":"Crit Rev Oncog"},{"issue":"1","key":"732_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/gte.2005.9.26","volume":"9","author":"D Elstein","year":"2005","unstructured":"Elstein D, Scott CR, Zeigler M, Abrahamov A, Zimran A: Phenotypic heterogeneity in patients with Gaucher disease and the N370S\/V394L genotype. Genet Test. 2005, 9 (1): 26-29. 10.1089\/gte.2005.9.26.","journal-title":"Genet Test"},{"issue":"24","key":"732_CR25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, Bar-Shira A, Orr-Urtreger A: Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology. 2008, 70 (24): 2277-2283. 10.1212\/01.wnl.0000304039.11891.29.","journal-title":"Neurology"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","volume":"31","author":"C Fairley","year":"2008","unstructured":"Fairley C, Zimran A, Phillips M, Cizmarik M, Yee J, Weinreb N, Packman S: Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher registry. J Inherit Metab Dis. 2008, 31: 738-744. 10.1007\/s10545-008-0868-z.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"732_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","volume":"36","author":"NJ Weinreb","year":"2013","unstructured":"Weinreb NJ, Goldblatt J, Villalobos J, Charrow J, Cole JA, Kerstenetzky M, Vom Dahl S, Hollak C: Long-term clinical outcomes in type 1 Gaucher disease following 10\u00a0years of imiglucerase treatment. J Inherit Metab Dis. 2013, 36 (3): 543-553. 10.1007\/s10545-012-9528-4.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"732_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bcmd.2010.10.015","volume":"47","author":"DA Hughes","year":"2011","unstructured":"Hughes DA, Al-Sayed M, Belmatoug N, Bodamer O, B\u00f6ttcher T, Cappellini M, Cohen IJ, Eagleton T, Elstein D, Giraldo P, Jones S, Kaplinsky C, Lund A, Machaczka M, Mengel E, Pastores GM, Rosenbaum H, Sjo M, Tiling N, Tsaftaridis P, Zimran A, Weinreb N: Early access experience with VPRIV(\u00ae): recommendations for \u2018core data\u2019 collection. Blood Cells Mol Dis. 2011, 47 (2): 140-142. 10.1016\/j.bcmd.2010.10.015. 10.1016\/j.bcmd.2010.10.015","journal-title":"Blood Cells Mol Dis"},{"issue":"7040","key":"732_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","volume":"312","author":"N Black","year":"1996","unstructured":"Black N: Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996, 312 (7040): 1215-1218. 10.1136\/bmj.312.7040.1215.","journal-title":"BMJ"},{"key":"732_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.7326\/0003-4819-158-12-201306180-00010","volume":"158","author":"D Resnick","year":"2013","unstructured":"Resnick D, Bozic KJ: Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?. Ann Intern Med. 2013, 158: 912-913. 10.7326\/0003-4819-158-12-201306180-00010. 10.7326\/0003-4819-158-12-201306180-00010","journal-title":"Ann Intern Med"},{"key":"732_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","volume":"83","author":"E Sidransky","year":"2004","unstructured":"Sidransky E: Gaucher disease: complexity in a \u201csimple\u201d disorder. Mol Genet Metab. 2004, 83: 6-15. 10.1016\/j.ymgme.2004.08.015.","journal-title":"Mol Genet Metab"},{"key":"732_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","volume":"21","author":"CF Snyder","year":"2012","unstructured":"Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M: Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012, 21: 1305-1314. 10.1007\/s11136-011-0054-x. doi:10.1007\/s11136-011-0054-x","journal-title":"Qual Life Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-9-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:25:57Z","timestamp":1630553157000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-9-45","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]},"assertion":[{"value":"23 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}